U.S. markets closed

Catalyst Pharmaceuticals, Inc. (CPRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
3.5300+0.0300 (+0.86%)
At close: 4:00PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
Total Revenue
118,180
102,306
500
0
Cost of Revenue
16,568
14,759
-
-
Gross Profit
101,613
87,547
-
-
Operating Expense
60,921
55,724
35,795
18,680
Operating Income
40,692
31,823
-35,295
-18,680
Net Non Operating Interest Income Expense
-
1,586
1,292
454.163
Other Income Expense
879.752
1,586
1,292
267.259
Pretax Income
41,572
33,409
-34,004
-18,412
Tax Provision
-29,904
1,534
0
0
Net Income Common Stockholders
71,476
31,875
-34,004
-18,412
Diluted NI Available to Com Stockholders
71,476
31,875
-34,004
-18,412
Basic EPS
-
0
0
0
Diluted EPS
-
0
0
0
Basic Average Shares
-
102,944
102,634
85,802
Diluted Average Shares
-
106,021
102,634
85,802
Total Operating Income as Reported
40,692
31,823
-35,295
-18,680
Total Expenses
77,488
70,483
35,795
18,680
Net Income from Continuing & Discontinued Operation
71,476
31,875
-34,004
-18,412
Normalized Income
71,476
31,875
-34,004
-18,225
Interest Income
-
1,586
1,292
454.163
Net Interest Income
-
1,586
1,292
454.163
EBIT
40,692
31,823
-35,295
-18,680
EBITDA
41,636
-
-
-
Reconciled Cost of Revenue
16,568
14,759
-
-
Reconciled Depreciation
943.538
297.726
37.978
45.689
Net Income from Continuing Operation Net Minority Interest
71,476
31,875
-34,004
-18,412
Total Unusual Items Excluding Goodwill
-
-
-
-186.904
Total Unusual Items
-
-
-
-186.904
Normalized EBITDA
41,636
32,121
-35,257
-18,447
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0

Premium access required.

Learn more